(Q44580623)

English

Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

2

object named as

Ronald N Jones

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Paul R Rhomberg

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

MYSTIC Program (USA) Study Group

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

365-372

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A European study on the relationship between antimicrobial use and antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The use and resistance to antibiotics in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance in Italy: four-year results from the MYSTIC program

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance in gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

MYSTIC program: summary of European data from 1997 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

ICU-acquired nosocomial infection: impact of delay of adequate antibiotic treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Unit differences in pathogen occurrence arising from the MYSTIC program European database (1997-2000).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas)

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(03)00112-3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44580623&oldid=2028619367"